MétaCan
Menu
Back to cohort
Record W4415958301 · doi:10.26685/urncst.918

Lipid Nanoparticles for Nucleic Acid Delivery and Gene Therapy: A Comprehensive Review

2025· article· W4415958301 on OpenAlexaff
S. Lynn

Bibliographic record

VenueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2025
Typearticle
Language
FieldBiochemistry, Genetics and Molecular Biology
TopicRNA Interference and Gene Delivery
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsNucleic acidEndosomeGene deliveryInternalizationGenetic enhancementDrug deliveryRNA interferenceGene silencing

Abstract

fetched live from OpenAlex

Introduction: Conventional drug delivery systems face significant limitations for nucleic acid therapeutics, including poor bioavailability, instability, and inefficient cellular uptake. Lipid nanoparticles have emerged as a transformative platform for nucleic acid delivery and gene therapy. These systems provide essential protection from degradation while enabling efficient cellular internalization and endosomal escape. Methods: A systematic analysis of 45 publications (2004-2025) from National Institutes of Health and PubMed databases was conducted. This analysis evaluated lipid nanoparticle technologies for nucleic acid delivery, focusing on fundamental design principles, optimization strategies, and targeting mechanisms for gene therapy applications. Results: This review identifies critical advances in lipid nanoparticle technology across three domains: fundamental design principles, optimization strategies, and targeting approaches. Lipid nanoparticles utilize pH-dependent endosomal escape mechanisms through ionizable lipids with optimized pKa values (6.2-6.5 for liver targeting, 6.6-6.9 for vaccines). Branched-tail lipidoid architectures demonstrate tenfold improved potency over linear analogs through enhanced endosomal ionization. Microfluidic manufacturing achieves >90% encapsulation efficiency with polydispersity indices ≤0.25. Clinical validation includes COVID-19 mRNA vaccines achieving >94% efficacy. Gene editing applications like VERVE-101 demonstrate sustained genetic modifications. Discussion: Despite significant technological advances, challenges persist in manufacturing scalability, targeting specificity, and methodological standardization across diverse ionizable lipid libraries. Safety considerations require careful evaluation of dose-dependent toxicity profiles, while regulatory frameworks must address manufacturing scalability and quality control for gene therapy applications. Conclusion: Lipid nanoparticle technology has revolutionized nucleic acid delivery and gene therapy through innovations in ionizable lipid design, manufacturing optimization, and targeting strategies. Critical challenges remain in targeting efficiency and endosomal escape mechanisms. Future developments should prioritize enhanced targeting specificity, improved biocompatibility, and standardized evaluation protocols to advance precision genetic therapeutics.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0030.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.411
Teacher spread0.350 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) JournalSame topicRNA Interference and Gene DeliveryFrench-language works237,207